Table 1.
Baseline characteristics by treatment group among the PAADRN participants (N = 7,749)
| Intervention (N = 3,898) | Control (N = 3,851) | P-Value | |
|---|---|---|---|
| Sociodemographics | |||
| Age, mean (SD) | 66.5 (8.4) | 66.7 (8.2) | 0.2461 |
| Women, N (%) | 3,259 (83.6) | 3,230 (83.9) | 0.7502 |
| Race/Ethnicity | |||
| White, N (%) | 2,981 (76.5) | 2,954 (76.7) | 0.6992 |
| Black, N (%) | 842 (21.6) | 814 (21.1) | |
| Other, N (%) | 75 (1.9) | 83 (2.2) | |
| Education | |||
| Some high school, N (%) | 161 (4.2) | 140 (3.7) | 0.7492 |
| Completed high school, N (%) | 819 (21.2) | 836 (21.9) | |
| Some college, N (%) | 1,290 (33.4) | 1,269 (33.2) | |
| Completed college, N (%) | 785 (20.3) | 762 (19.9) | |
| Graduate school, N (%) | 809 (20.9) | 814 (21.3) | |
| Comorbid Conditions | |||
| COPD, N (%) | 259 (6.7) | 265 (6.9) | 0.6802 |
| Depression, N (%) | 902 (23.2) | 885 (23.0) | 0.8782 |
| Prostate cancer, N (%) | 117 (18.3) | 88 (14.2) | 0.0482 |
| Breast cancer, N (%) | 416 (10.7) | 612 (15.9) | <0.0012 |
| Health Habits | |||
| Current smoker, N (%) | 295 (7.6) | 295 (7.7) | 0.8732 |
| Past smoker, N (%) | 1,478 (37.9) | 1,388 (36.1) | 0.0952 |
| Current alcohol user, N (%) | 1,768 (45.4) | 1,808 (47.0) | 0.1572 |
| Self-reported Health Status | |||
| Excellent, N (%) | 445 (11.4) | 494 (12.8) | 0.3292 |
| Very Good, N (%) | 1,443 (37.1) | 1,373 (35.7) | |
| Good, N (%) | 1,280 (32.9) | 1,253 (32.6) | |
| Fair, N (%) | 571 (14.7) | 566 (14.7) | |
| Poor, N (%) | 150 (3.9) | 159 (4.1) | |
| Bone Health | |||
| Prior DXA, N (%) | 2,606 (66.9) | 2,590 (67.3) | 0.7192 |
| History of OP, N (%) | 794 (20.6) | 909 (23.8) | 0.0012 |
| History of OP treatment, N (%) | 1,438 (36.9) | 1,502 (39.0) | 0.0552 |
| Glucocorticoids Use, N (%) | 593 (15.2) | 576 (15.0) | 0.7532 |
| Study DXA Results | |||
| Normal, N (%) | 1,133 (29.1) | 990 (25.7) | 0.0012 |
| Low BMD, N (%) | 2,052 (52.6) | 2,066 (53.6) | |
| Osteoporosis, N (%) | 713 (18.3) | 795 (20.6) | |
| Lowest T-Score, mean (SD) | -1.62 (1.1) | -1.55 (1.1) | 0.0021 |
| 10-year Fracture Risk (FRAX), mean (SD) | 12.0 (9.2) | 12.3 (9.1) | 0.1011 |
1 P-value from Two-sample T-Test
2 P-value is from Pearson Chi-square Test